Document Detail


The non-bleeding visible vessel versus the sentinel clot: natural history and risk of rebleeding.
MedLine Citation:
PMID:  8514066     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Non-bleeding visible vessel and sentinel clot are terms used interchangeably to describe protuberances in the base of ulcers that have recently bled, but a consensus as to their definition or natural history does not exist. In patients with severe ulcer hemorrhage, non-bleeding protuberances were classified as vessels, with or without a small attached clot, or as sentinel clots, according to a schema based on the appearance of the protuberance at endoscopy but not subjected to pathologic correlation. Endoscopic therapy was not performed at the index endoscopic evaluation, and natural evolution was prospectively documented with daily videoendoscopy. Eleven (46%) of 24 patients with non-bleeding protuberances had rebleeding. Independent classification by three authors concurred in 18 (75%) of 24 lesions. Ten (91%) of 11 vessels with or without attached clot rebled versus 0 (0%) of 7 sentinel clots and 1 (17%) of 6 lesions without unanimous classification (p < 0.01, vessels versus other groups). Rebleeding occurred in 5 (71%) of 7 nonpigmented (pale or white), 6 (38%) of 16 red or purple, and 0 (0%) of 1 black protuberances. In general, vessels persisted until rebleeding, whereas sentinel clots disappeared within 1 to 3 days. We conclude that nonbleeding protuberances in ulcer bases can be separated into vessels, which have a high risk of rebleeding, and sentinel clots, which have a low risk of rebleeding.
Authors:
M L Freeman; O W Cass; C J Peine; G R Onstad
Related Documents :
12620556 - How many cases are enough for accreditation in sentinel lymph node biopsy in breast can...
10580766 - Supradiaphragmatic manifestations of papillary serous adenocarcinoma of the ovary.
19042946 - Determination of the irradiation field for clinical t1-t3n0m0 thoracic/abdominal esopha...
11432376 - Lymphoscintigraphy and lymphatic mapping for identification of sentinel lymph nodes.
501756 - The unrewarding results of curative therapy in esophageal cancer.
20127946 - Introduction to the supplement, "cancer therapy with antibodies and immunoconjugates".
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  Gastrointestinal endoscopy     Volume:  39     ISSN:  0016-5107     ISO Abbreviation:  Gastrointest. Endosc.     Publication Date:    1993 May-Jun
Date Detail:
Created Date:  1993-07-22     Completed Date:  1993-07-22     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0010505     Medline TA:  Gastrointest Endosc     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  359-66     Citation Subset:  IM    
Affiliation:
Department of Medicine, Hennepin County Medical Center, Minneapolis, Minnesota 55415.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Blood Coagulation
Blood Vessels / pathology
Duodenal Ulcer / complications*,  pathology
Endoscopy, Digestive System
Female
Humans
Male
Middle Aged
Peptic Ulcer Hemorrhage / blood,  epidemiology*,  pathology
Prospective Studies
Recurrence
Risk Factors
Stomach Ulcer / complications*,  pathology
Comments/Corrections
Comment In:
Gastrointest Endosc. 1994 Sep-Oct;40(5):648   [PMID:  7988839 ]
Gastrointest Endosc. 1993 May-Jun;39(3):461-2   [PMID:  8514088 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Transforming growth factor beta regulation of migration in wounded rat intestinal epithelial monolay...
Next Document:  Endoscopy of the pancreatic duct: value of different endoscope types.